MiMedx Group (MDXG) Analyst & Key Data

Analyst Consensus

Buy4 analysts

Buy

Updated Sep 12, 2026

Total Analysts4

Buy

12

Hold

1

Sell

2

Ratings

Updated Sep 12, 2026

Overall Rating

B+

DCF Score4.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score4.0 / 5

ROE Score3.0 / 5

Valuation

Current Stock Price

$4.57

Median Target+80.53%

$8.25

Potential upside vs current price

DCF Value-18.95%

$3.70

Potential downside vs current price

Current Stock Price

$4.57

Median Target+80.53%

$8.25

Potential upside vs current price

DCF Value-18.95%

$3.70

Potential downside vs current price

Analyst Consensus

Buy4 analysts

Buy

Updated Sep 12, 2026

Total Analysts4

Buy

12

Hold

1

Sell

2

Ratings

Updated Sep 12, 2026

Overall Rating

B+

DCF Score4.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score4.0 / 5

ROE Score3.0 / 5

Valuation

Current Stock Price

$4.57

Median Target+80.53%

$8.25

Potential upside vs current price

DCF Value-18.95%

$3.70

Potential downside vs current price

Current Stock Price

$4.57

Median Target+80.53%

$8.25

Potential upside vs current price

DCF Value-18.95%

$3.70

Potential downside vs current price

MiMedx Group, Inc.